Darryl W.

Chief Financial Officer @Gentronix, Part Of Scantox Group

Alderley Edge, GB

Finance leader for specialist genetic & skin / ocular toxicology CRO, supporting the development of safe medicines, chemicals and cosmetics. Responsible for all areas of finance including performance reporting to Board, FP & A, strategy, governance and capital allocation.Supported strategy development and execution, capital deployment and new customer on-boarding to allow business scale up with revenue growth >60% and EBITDA growth >100%. Lead successful exit for Mercia VCTs via auction process that completed in Sep 2024 with full equity sale to Scantox Group / Impilo PE. Process included strategic financial plan build, sell side Financial, Tax and Commercial DD, Teaser & CIM production, multiple pre-bid qualification meetings, Management Presentation preparation and participation across 5x bidders, VDR build, Q&A responses / buy side DD, EV Equity bridge negotiation, funds flow and proceeds waterfall planning, final SPA negotiation. Post deal integration activity around legal post-completion steps, banking, audit, PPA valuation and group systems deployment.Implemented MI improvements on leading indicators (pipeline, backlog, contract schedules), 13 week rolling multi-currency cashflow forecasting to improve liquidity management. Added transactional resource capacity and credit control processes to improve DSO and cashflow. Bolt on M&A opportunity scenario modelling and valuation range setting for Group board.

Ridge Danyers

A Levels, maths, physics, chemistry

ICAEW

ACA, Accounting and Finance

The University of Manchester

Bachelor of Engineering (B.Eng.), Chemical Engineering

Kingsway

GCSE's